Visits: 1194, Avg visit time (secs): 240,29 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 475 | 39,78% | |
| /amylin/efsd-amylin-rfa10.html | 239 | 20,02% |
| /programmes.html | 115 | 9,63% |
| /amylin/efsd-amylin-rfa09.html | 47 | 3,94% |
| /cr grant/efsd-clinresgrant-rfa10.html | 46 | 3,85% |
| /msd/clinical/efsd-msd-clinical-rfa10.html | 24 | 2,01% |
| /msd/clinical/efsd-msd-clinical-rfa09.html | 17 | 1,42% |
| /new_horizons/new-horizons10.html | 17 | 1,42% |
| /msd/albert-renold/efsd-msd-arenold.html | 16 | 1,34% |
| /lilly/fellowships/efsd-lilly-fship10.html | 15 | 1,26% |
| /dcure/efsd-dcure-rfa10.html | 15 | 1,26% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 462 | 38,69% |
| /sanofi-aventis/micro_macro/s-a 10 rfa.html | 259 | 21,69% |
| /dcure/efsd-dcure-rfa10.html | 60 | 5,03% |
| / | 43 | 3,60% |
| /lilly/fellowships/efsd-lilly-fship10.html | 37 | 3,10% |
| /programmes.html | 26 | 2,18% |
| /new_horizons/new-horizons10.html | 25 | 2,09% |
| /msd/clinical/efsd-msd-clinical-rfa10.html | 24 | 2,01% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-mv-rfa09.html | 23 | 1,93% |
| /cr grant/efsd-clinresgrant-rfa10.html | 22 | 1,84% |
| /pfizer/efsd-pfizer-rfa10.html | 19 | 1,59% |